FemPulse gets FDA approval to test a new vaginal device for overactive bladder in women.
FemPulse has received FDA approval to begin a clinical trial for its new device designed to treat overactive bladder in women. The wearable device, inserted vaginally, aims to provide continuous nerve stimulation as an alternative to medication. If successful, it could offer a new treatment option for millions of women suffering from OAB. The company is also seeking regulatory approval in Europe for the device.
4 months ago
3 Articles
Further Reading
This is your last free story for the month. Don’t miss out — Subscribe now for unlimited access!